Contribution of the -455G/A polymorphism at β-fibrinogen gene and of the Leiden mutation to hemorheological parameters in ischemic stroke patients

Clinical Hemorheology and Microcirculation

Volumn 35, Issue 1-2, 2006, Pages 75-82

  Pongrácz, Endre ^a   Andrikovics, Hajnalka ^b   Csornai, Márta ^c   Bernát, Iván S ^d   Nagy, Zoltán ^e  

^a Central Hospital of Home Office   (Hungary)

^b National Institute of Hemathology   (Hungary)

^c 1st Department of Internal Medicine   (Hungary)

^d Central Military Hospital Budapest   (Hungary)

^e SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

445 fibrinogen; Blood viscosity; Genetic polymorphisms; Hemorheology; Ischemic stroke; Leiden mutation; Plasma viscosity

Indexed keywords

FIBRINOGEN; FIBRINOGEN B BETA CHAIN; UNCLASSIFIED DRUG;

ADULT; AGED; BLOOD RHEOLOGY; BLOOD VISCOSITY; CEREBROVASCULAR ACCIDENT; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMA VISCOSITY; POLYMERASE CHAIN REACTION; PREVALENCE; WILD TYPE;

AGED; BLOOD VISCOSITY; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHI-SQUARE DISTRIBUTION; FACTOR V; FEMALE; FIBRINOGEN; GENOTYPE; HEMORHEOLOGY; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; SMOKING;

EID: 33746428584     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. American Heart Association, in: Heart Disease and Stroke Statistics 2003 Update, Statistical Office of the European Communities, 2002.
2. H. Markus, ed., Stroke Genetics, Oxford Univ. Press. Inc., New York, 2003.
3. G. Maresca, A. Di Blasio, R. Marchioli, G. Di Minno, Measuring plasma fibrinogen to predict stroke and myocardial infarction. An update, Arterioscler. Thromb. Vasc. Biol. 19 (1999), 1368-1377.
4. S. Nishiuma, K. Kario, K. Yakushijin, M. Maeda, R. Murai, T. Matsuo, U. Ikeda, K. Shimada and M. Matsuo, Genetic variation in the promoter region of the beta-fibrinogen gene is associated with ischemic stroke in a Japanese population, Blood Coagul Fibrinolysis 9 (1998), 373-379.
5. A. Tybjaerg-Hansen, B. Agerholm-Larsen, S.E. Humphries, S. Abildgaard, P. Schnohr and B.G. Nordestgaard, A common mutation (G-455→ A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9.127 individuals based on the Copenhagen City Heart Study, J. Clin. Invest. 12 (1997), 3034-3039.
6. A.M. Carter, M.W. Mansfield, M.H. Stickland and P.J. Grant, B-fibrinogen gene -4555G/A polymorphism and fibrinogen levels: risk factors for coronary artery disease in subjetcs with NIDD, Diabetes Care 19 (1996), 1265-1268.
7. A.R. Folsom, N. Aleksic, C. Ahn, E. Boerwinkle and K.K. Wu, Beta-fibrinogen gene -455G/A polymorphism and coronary heart disease incidence: the Atherosclerosis Risk in Communities (ARIC) Study, Ann. Epidemiol. 11 (2001), 166-170.
8. W.T. Longstreth, F.R. Rosendal, D.S. Siscovick, H.L. Vos, S.M. Schwartz, B.M. Psaty, T.E. Raghunathan, T.D. Koepsell and P.H. Reitsma, Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant, Stroke 29 (1998), 577-580.
9. S.A. Miller, D.D. Dykes and H.F. Polesky, A simple salting out for extracting DNA from human nucleated cells, Nucleic Acids Res. 16 (1988), 1215-1220.
10. A.E. Thomas, F.R. Green, C.H. Kelleher, H.C. Wilkes, P.J. Brennan, T.W. Meade and S.E. Humphries, Variation in the promoter region of the beta fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers, Thromb. Haemost. 65 (1991), 487-490.
11. R.M. Bertina, B.P.C. Koeleman, T. Koster, F.R. Rosendal, R.J. Dirven, H. de Ronde, P.A. van der Velden and P.H. Reitsma, Mutation in blood coagulation factor V associated with resistance to activated protein C, Nature 369 (1994), 64-67.
12. A. Matrai, P.T. Flute and J. Dormandy, Improving accuracy of co-axial viscometry, Biorheology 8(Suppl. 1) (1984), 99.
13. A. von Clauss, Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens, Acta Haematol. 17 (1957), 237-246.
14. C. Kessler, C. Spitzer, D. Stauske, S. Mende, J. Stadlmuller, R. Walther and R. Rettig, The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease, Arterioscler. Thromb. Vasc. Biol. 17 (1997), 2880-2884.
15. S. Stefano, B.-M. Caterina, T. Elisabetta, C. Alessandro, M. Pasquale and P. Pier Franco, Frequency of Factor V Leiden in juvenile migraine with aura, Headache 38 (1998), 779-781.
16. W.T. Longstreth, F.R. Rosendal, D.S. Siscovick, H.L. Vos, S.M. Schwartz, B.M. Psaty, T.E. Raghunathan, T.D. Koepsell and P.H. Reitsma, Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant, Stroke 29 (1998), 577-580.
17. E. Pongracz, A. Tordai, M. Csornai, Zs. Bela and Z. Nagy, Significance of Factor V gene A506G mutation (Leiden) in the pathogenesis of ischemic stroke, Ideggyogy Sz./Clin. Neurosci. 20 (2003), 157-164.
18. X. Weng, G. Cloutier and J. Genest, Jr., Contribution of the -455G/A polymorphism at the beta-fibrinogen gene to crythrocyte aggregation in patients with coronary artery disease, Thromb. Haemost. 82(1999), 1406-1411.
19. C. Andrew, B.S. Parker, V. Lakshmi, M.S. Mundada, H. Alvin, M.D. Schmaier, P. William and M.D. Fay, Factor V Leiden inhibits fibrinolysis in vivo, Circulation 110 (2004), 3594-3598.